TSP48938-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to efaproxiral


TSA207543-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to efaproxiral


TSA207577-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to efaproxiral


TSA207619-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to efaproxiral


TSA207669-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to efaproxiral


TSA207724-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to efaproxiral


TSA207779-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to efaproxiral


TSA207827-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to efaproxiral


TSA207883-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to efaproxiral


TSA207938-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to efaproxiral


TSA207992-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to efaproxiral


TSA208018-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to efaproxiral


TSA208071-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to efaproxiral


TSA208101-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to efaproxiral


TSA208153-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to efaproxiral


TSF464293-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to efaproxiral 10.0 µM for 24.0 h


1 subfactor(s)
TSF464294-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to efaproxiral 3.33 µM for 24.0 h


1 subfactor(s)
TSF464295-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to efaproxiral 1.11 µM for 24.0 h


1 subfactor(s)
TSF464296-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to efaproxiral 0.37 µM for 24.0 h


1 subfactor(s)
TSF464297-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to efaproxiral 0.125 µM for 24.0 h


1 subfactor(s)
TSF464298-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to efaproxiral 0.04 µM for 24.0 h


1 subfactor(s)
TSF569114-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to efaproxiral 0.74 µM for 24.0 h


1 subfactor(s)
TSF569115-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to efaproxiral 0.25 µM for 24.0 h


1 subfactor(s)
TSF569113-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to efaproxiral 2.22 µM for 24.0 h


1 subfactor(s)
TSF569116-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to efaproxiral 0.08 µM for 24.0 h


1 subfactor(s)
TSF569117-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to efaproxiral 0.03 µM for 24.0 h


1 subfactor(s)
TSF569118-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to efaproxiral 0.01 µM for 24.0 h


1 subfactor(s)
TSF464588-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to efaproxiral 0.125 µM for 24.0 h


1 subfactor(s)
TSF464584-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to efaproxiral 10.0 µM for 24.0 h


1 subfactor(s)
TSF464585-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to efaproxiral 3.33 µM for 24.0 h


1 subfactor(s)
TSF464589-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to efaproxiral 0.04 µM for 24.0 h


1 subfactor(s)
TSF464586-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to efaproxiral 1.11 µM for 24.0 h


1 subfactor(s)
TSF464587-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to efaproxiral 0.37 µM for 24.0 h


1 subfactor(s)
TSF569446-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to efaproxiral 2.22 µM for 24.0 h


1 subfactor(s)
TSF569447-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to efaproxiral 0.74 µM for 24.0 h


1 subfactor(s)
TSF569448-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to efaproxiral 0.25 µM for 24.0 h


1 subfactor(s)
TSF569449-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to efaproxiral 0.08 µM for 24.0 h


1 subfactor(s)
TSF569450-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to efaproxiral 0.03 µM for 24.0 h


1 subfactor(s)
TSF569451-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to efaproxiral 0.01 µM for 24.0 h


1 subfactor(s)
TSF464896-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to efaproxiral 0.04 µM for 24.0 h


1 subfactor(s)
TSF464891-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to efaproxiral 10.0 µM for 24.0 h


1 subfactor(s)
TSF464892-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to efaproxiral 3.33 µM for 24.0 h


1 subfactor(s)
TSF464893-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to efaproxiral 1.11 µM for 24.0 h


1 subfactor(s)
TSF464894-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to efaproxiral 0.37 µM for 24.0 h


1 subfactor(s)
TSF464895-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to efaproxiral 0.125 µM for 24.0 h


1 subfactor(s)
TSF569776-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to efaproxiral 2.22 µM for 24.0 h


1 subfactor(s)
TSF569777-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to efaproxiral 0.74 µM for 24.0 h


1 subfactor(s)
TSF569778-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to efaproxiral 0.25 µM for 24.0 h


1 subfactor(s)
TSF569779-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to efaproxiral 0.08 µM for 24.0 h


1 subfactor(s)
TSF569780-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to efaproxiral 0.03 µM for 24.0 h


1 subfactor(s)
TSF569781-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to efaproxiral 0.01 µM for 24.0 h


1 subfactor(s)
TSF465208-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to efaproxiral 10.0 µM for 24.0 h


1 subfactor(s)
TSF465209-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to efaproxiral 3.33 µM for 24.0 h


1 subfactor(s)
TSF465210-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to efaproxiral 1.11 µM for 24.0 h


1 subfactor(s)
TSF465211-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to efaproxiral 0.37 µM for 24.0 h


1 subfactor(s)
TSF465212-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to efaproxiral 0.125 µM for 24.0 h


1 subfactor(s)
TSF465213-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to efaproxiral 0.04 µM for 24.0 h


1 subfactor(s)
TSF570111-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to efaproxiral 2.22 µM for 24.0 h


1 subfactor(s)
TSF570112-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to efaproxiral 0.74 µM for 24.0 h


1 subfactor(s)
TSF570113-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to efaproxiral 0.25 µM for 24.0 h


1 subfactor(s)
TSF570114-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to efaproxiral 0.08 µM for 24.0 h


1 subfactor(s)
TSF570115-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to efaproxiral 0.03 µM for 24.0 h


1 subfactor(s)
TSF570116-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to efaproxiral 0.01 µM for 24.0 h


1 subfactor(s)
TSF465539-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to efaproxiral 10.0 µM for 24.0 h


1 subfactor(s)
TSF465540-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to efaproxiral 3.33 µM for 24.0 h


1 subfactor(s)
TSF465541-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to efaproxiral 1.11 µM for 24.0 h


1 subfactor(s)
TSF465542-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to efaproxiral 0.37 µM for 24.0 h


1 subfactor(s)
TSF465543-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to efaproxiral 0.125 µM for 24.0 h


1 subfactor(s)
TSF465544-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to efaproxiral 0.04 µM for 24.0 h


1 subfactor(s)
TSF570449-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to efaproxiral 0.08 µM for 24.0 h


1 subfactor(s)
TSF570446-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to efaproxiral 2.22 µM for 24.0 h


1 subfactor(s)
TSF570450-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to efaproxiral 0.03 µM for 24.0 h


1 subfactor(s)
TSF570447-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to efaproxiral 0.74 µM for 24.0 h


1 subfactor(s)
TSF570448-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to efaproxiral 0.25 µM for 24.0 h


1 subfactor(s)
TSF570451-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to efaproxiral 0.01 µM for 24.0 h


1 subfactor(s)
TSF465872-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to efaproxiral 1.11 µM for 24.0 h


1 subfactor(s)
TSF465870-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to efaproxiral 10.0 µM for 24.0 h


1 subfactor(s)
TSF465871-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to efaproxiral 3.33 µM for 24.0 h


1 subfactor(s)
TSF465875-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to efaproxiral 0.04 µM for 24.0 h


1 subfactor(s)
TSF465873-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to efaproxiral 0.37 µM for 24.0 h


1 subfactor(s)
TSF465874-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to efaproxiral 0.125 µM for 24.0 h


1 subfactor(s)
TSF570782-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to efaproxiral 0.25 µM for 24.0 h


1 subfactor(s)
TSF570783-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to efaproxiral 0.08 µM for 24.0 h


1 subfactor(s)
TSF570780-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to efaproxiral 2.22 µM for 24.0 h


1 subfactor(s)
TSF570781-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to efaproxiral 0.74 µM for 24.0 h


1 subfactor(s)
TSF570784-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to efaproxiral 0.03 µM for 24.0 h


1 subfactor(s)
TSF570785-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to efaproxiral 0.01 µM for 24.0 h


1 subfactor(s)
TSF466193-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to efaproxiral 1.11 µM for 24.0 h


1 subfactor(s)
TSF466191-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to efaproxiral 10.0 µM for 24.0 h


1 subfactor(s)
TSF466192-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to efaproxiral 3.33 µM for 24.0 h


1 subfactor(s)
TSF466194-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to efaproxiral 0.37 µM for 24.0 h


1 subfactor(s)
TSF466195-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to efaproxiral 0.125 µM for 24.0 h


1 subfactor(s)
TSF466196-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to efaproxiral 0.04 µM for 24.0 h


1 subfactor(s)
TSF571118-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to efaproxiral 0.08 µM for 24.0 h


1 subfactor(s)
TSF571115-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to efaproxiral 2.22 µM for 24.0 h


1 subfactor(s)
TSF571116-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to efaproxiral 0.74 µM for 24.0 h


1 subfactor(s)
TSF571117-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to efaproxiral 0.25 µM for 24.0 h


1 subfactor(s)
TSF571119-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to efaproxiral 0.03 µM for 24.0 h


1 subfactor(s)
TSF571120-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to efaproxiral 0.01 µM for 24.0 h


1 subfactor(s)
TSF466517-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to efaproxiral 10.0 µM for 24.0 h


1 subfactor(s)
TSF466518-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to efaproxiral 3.33 µM for 24.0 h


1 subfactor(s)
TSF466519-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to efaproxiral 1.11 µM for 24.0 h


1 subfactor(s)
TSF466520-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to efaproxiral 0.37 µM for 24.0 h


1 subfactor(s)
TSF466521-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to efaproxiral 0.125 µM for 24.0 h


1 subfactor(s)
TSF466522-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to efaproxiral 0.04 µM for 24.0 h


1 subfactor(s)
TSF571452-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to efaproxiral 0.25 µM for 24.0 h


1 subfactor(s)
TSF571450-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to efaproxiral 2.22 µM for 24.0 h


1 subfactor(s)
TSF571451-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to efaproxiral 0.74 µM for 24.0 h


1 subfactor(s)
TSF571454-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to efaproxiral 0.03 µM for 24.0 h


1 subfactor(s)
TSF571453-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to efaproxiral 0.08 µM for 24.0 h


1 subfactor(s)
TSF571455-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to efaproxiral 0.01 µM for 24.0 h


1 subfactor(s)
TSF466847-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to efaproxiral 10.0 µM for 24.0 h


1 subfactor(s)
TSF466850-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to efaproxiral 0.37 µM for 24.0 h


1 subfactor(s)
TSF466848-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to efaproxiral 3.33 µM for 24.0 h


1 subfactor(s)
TSF466849-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to efaproxiral 1.11 µM for 24.0 h


1 subfactor(s)
TSF466852-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to efaproxiral 0.04 µM for 24.0 h


1 subfactor(s)
TSF466851-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to efaproxiral 0.125 µM for 24.0 h


1 subfactor(s)
TSF571786-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to efaproxiral 0.74 µM for 24.0 h


1 subfactor(s)
TSF571785-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to efaproxiral 2.22 µM for 24.0 h


1 subfactor(s)
TSF571787-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to efaproxiral 0.25 µM for 24.0 h


1 subfactor(s)
TSF571788-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to efaproxiral 0.08 µM for 24.0 h


1 subfactor(s)
TSF571789-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to efaproxiral 0.03 µM for 24.0 h


1 subfactor(s)
TSF571790-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to efaproxiral 0.01 µM for 24.0 h


1 subfactor(s)
TSF467177-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to efaproxiral 10.0 µM for 24.0 h


1 subfactor(s)
TSF467178-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to efaproxiral 3.33 µM for 24.0 h


1 subfactor(s)
TSF467179-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to efaproxiral 1.11 µM for 24.0 h


1 subfactor(s)
TSF467180-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to efaproxiral 0.37 µM for 24.0 h


1 subfactor(s)
TSF467181-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to efaproxiral 0.125 µM for 24.0 h


1 subfactor(s)
TSF467182-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to efaproxiral 0.04 µM for 24.0 h


1 subfactor(s)
TSF572120-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to efaproxiral 2.22 µM for 24.0 h


1 subfactor(s)
TSF572121-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to efaproxiral 0.74 µM for 24.0 h


1 subfactor(s)
TSF572122-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to efaproxiral 0.25 µM for 24.0 h


1 subfactor(s)
TSF572123-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to efaproxiral 0.08 µM for 24.0 h


1 subfactor(s)
TSF572124-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to efaproxiral 0.03 µM for 24.0 h


1 subfactor(s)
TSF572125-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to efaproxiral 0.01 µM for 24.0 h


1 subfactor(s)
TSF467472-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to efaproxiral 10.0 µM for 24.0 h


1 subfactor(s)
TSF467473-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to efaproxiral 3.33 µM for 24.0 h


1 subfactor(s)
TSF467474-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to efaproxiral 1.11 µM for 24.0 h


1 subfactor(s)
TSF467475-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to efaproxiral 0.37 µM for 24.0 h


1 subfactor(s)
TSF467476-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to efaproxiral 0.125 µM for 24.0 h


1 subfactor(s)
TSF467477-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to efaproxiral 0.04 µM for 24.0 h


1 subfactor(s)
TSF572450-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to efaproxiral 2.22 µM for 24.0 h


1 subfactor(s)
TSF572451-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to efaproxiral 0.74 µM for 24.0 h


1 subfactor(s)
TSF572452-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to efaproxiral 0.25 µM for 24.0 h


1 subfactor(s)
TSF572453-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to efaproxiral 0.08 µM for 24.0 h


1 subfactor(s)
TSF572454-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to efaproxiral 0.03 µM for 24.0 h


1 subfactor(s)
TSF572455-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to efaproxiral 0.01 µM for 24.0 h


1 subfactor(s)
TSF467797-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to efaproxiral 10.0 µM for 24.0 h


1 subfactor(s)
TSF467800-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to efaproxiral 0.37 µM for 24.0 h


1 subfactor(s)
TSF467798-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to efaproxiral 3.33 µM for 24.0 h


1 subfactor(s)
TSF467799-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to efaproxiral 1.11 µM for 24.0 h


1 subfactor(s)
TSF467801-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to efaproxiral 0.125 µM for 24.0 h


1 subfactor(s)
TSF467802-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to efaproxiral 0.04 µM for 24.0 h


1 subfactor(s)
TSF572785-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to efaproxiral 2.22 µM for 24.0 h


1 subfactor(s)
TSF572790-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to efaproxiral 0.01 µM for 24.0 h


1 subfactor(s)
TSF572786-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to efaproxiral 0.74 µM for 24.0 h


1 subfactor(s)
TSF572787-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to efaproxiral 0.25 µM for 24.0 h


1 subfactor(s)
TSF572788-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to efaproxiral 0.08 µM for 24.0 h


1 subfactor(s)
TSF572789-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to efaproxiral 0.03 µM for 24.0 h


1 subfactor(s)
TSF468082-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to efaproxiral 1.11 µM for 24.0 h


1 subfactor(s)
TSF468080-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to efaproxiral 10.0 µM for 24.0 h


1 subfactor(s)
TSF468081-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to efaproxiral 3.33 µM for 24.0 h


1 subfactor(s)
TSF468083-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to efaproxiral 0.37 µM for 24.0 h


1 subfactor(s)
TSF468084-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to efaproxiral 0.125 µM for 24.0 h


1 subfactor(s)
TSF468085-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to efaproxiral 0.04 µM for 24.0 h


1 subfactor(s)
TSF573122-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to efaproxiral 0.08 µM for 24.0 h


1 subfactor(s)
TSF573119-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to efaproxiral 2.22 µM for 24.0 h


1 subfactor(s)
TSF573120-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to efaproxiral 0.74 µM for 24.0 h


1 subfactor(s)
TSF573121-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to efaproxiral 0.25 µM for 24.0 h


1 subfactor(s)
TSF573123-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to efaproxiral 0.03 µM for 24.0 h


1 subfactor(s)
TSF573124-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to efaproxiral 0.01 µM for 24.0 h


1 subfactor(s)
TSF468411-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to efaproxiral 10.0 µM for 24.0 h


1 subfactor(s)
TSF468414-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to efaproxiral 0.37 µM for 24.0 h


1 subfactor(s)
TSF468412-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to efaproxiral 3.33 µM for 24.0 h


1 subfactor(s)
TSF468413-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to efaproxiral 1.11 µM for 24.0 h


1 subfactor(s)
TSF468415-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to efaproxiral 0.125 µM for 24.0 h


1 subfactor(s)
TSF468416-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to efaproxiral 0.04 µM for 24.0 h


1 subfactor(s)
TSF573456-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to efaproxiral 0.25 µM for 24.0 h


1 subfactor(s)
TSF573459-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to efaproxiral 0.01 µM for 24.0 h


1 subfactor(s)
TSF573454-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to efaproxiral 2.22 µM for 24.0 h


1 subfactor(s)
TSF573455-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to efaproxiral 0.74 µM for 24.0 h


1 subfactor(s)
TSF573457-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to efaproxiral 0.08 µM for 24.0 h


1 subfactor(s)
TSF573458-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to efaproxiral 0.03 µM for 24.0 h


1 subfactor(s)
TSS464302-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to efaproxiral 10.0 µM for 24.0 h


TSS464303-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to efaproxiral 3.33 µM for 24.0 h


TSS464304-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to efaproxiral 1.11 µM for 24.0 h


TSS464305-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to efaproxiral 0.37 µM for 24.0 h


TSS464306-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to efaproxiral 0.125 µM for 24.0 h


TSS464307-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to efaproxiral 0.04 µM for 24.0 h


TSS569124-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to efaproxiral 0.74 µM for 24.0 h


TSS569125-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to efaproxiral 0.25 µM for 24.0 h


TSS569123-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to efaproxiral 2.22 µM for 24.0 h


TSS569126-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to efaproxiral 0.08 µM for 24.0 h


TSS569127-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to efaproxiral 0.03 µM for 24.0 h


TSS569128-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to efaproxiral 0.01 µM for 24.0 h


TSS464597-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to efaproxiral 0.125 µM for 24.0 h


TSS464593-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to efaproxiral 10.0 µM for 24.0 h


TSS464594-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to efaproxiral 3.33 µM for 24.0 h


TSS464598-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to efaproxiral 0.04 µM for 24.0 h


TSS464595-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to efaproxiral 1.11 µM for 24.0 h


TSS464596-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to efaproxiral 0.37 µM for 24.0 h


TSS569456-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to efaproxiral 2.22 µM for 24.0 h


TSS569457-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to efaproxiral 0.74 µM for 24.0 h


TSS569458-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to efaproxiral 0.25 µM for 24.0 h


TSS569459-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to efaproxiral 0.08 µM for 24.0 h


TSS569460-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to efaproxiral 0.03 µM for 24.0 h


TSS569461-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to efaproxiral 0.01 µM for 24.0 h


TSS464905-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to efaproxiral 0.04 µM for 24.0 h


TSS464900-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to efaproxiral 10.0 µM for 24.0 h


TSS464901-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to efaproxiral 3.33 µM for 24.0 h


TSS464902-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to efaproxiral 1.11 µM for 24.0 h


TSS464903-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to efaproxiral 0.37 µM for 24.0 h


TSS464904-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to efaproxiral 0.125 µM for 24.0 h


TSS569786-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to efaproxiral 2.22 µM for 24.0 h


TSS569787-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to efaproxiral 0.74 µM for 24.0 h


TSS569788-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to efaproxiral 0.25 µM for 24.0 h


TSS569789-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to efaproxiral 0.08 µM for 24.0 h


TSS569790-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to efaproxiral 0.03 µM for 24.0 h


TSS569791-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to efaproxiral 0.01 µM for 24.0 h


TSS465217-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to efaproxiral 10.0 µM for 24.0 h


TSS465218-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to efaproxiral 3.33 µM for 24.0 h


TSS465219-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to efaproxiral 1.11 µM for 24.0 h


TSS465220-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to efaproxiral 0.37 µM for 24.0 h


TSS465221-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to efaproxiral 0.125 µM for 24.0 h


TSS465222-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to efaproxiral 0.04 µM for 24.0 h


TSS570121-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to efaproxiral 2.22 µM for 24.0 h


TSS570122-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to efaproxiral 0.74 µM for 24.0 h


TSS570123-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to efaproxiral 0.25 µM for 24.0 h


TSS570124-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to efaproxiral 0.08 µM for 24.0 h


TSS570125-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to efaproxiral 0.03 µM for 24.0 h


TSS570126-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to efaproxiral 0.01 µM for 24.0 h


TSS465548-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to efaproxiral 10.0 µM for 24.0 h


TSS465549-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to efaproxiral 3.33 µM for 24.0 h


TSS465550-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to efaproxiral 1.11 µM for 24.0 h


TSS465551-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to efaproxiral 0.37 µM for 24.0 h


TSS465552-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to efaproxiral 0.125 µM for 24.0 h


TSS465553-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to efaproxiral 0.04 µM for 24.0 h


TSS570459-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to efaproxiral 0.08 µM for 24.0 h


TSS570456-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to efaproxiral 2.22 µM for 24.0 h


TSS570460-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to efaproxiral 0.03 µM for 24.0 h


TSS570457-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to efaproxiral 0.74 µM for 24.0 h


TSS570458-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to efaproxiral 0.25 µM for 24.0 h


TSS570461-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to efaproxiral 0.01 µM for 24.0 h


TSS465881-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to efaproxiral 1.11 µM for 24.0 h


TSS465879-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to efaproxiral 10.0 µM for 24.0 h


TSS465880-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to efaproxiral 3.33 µM for 24.0 h


TSS465884-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to efaproxiral 0.04 µM for 24.0 h


TSS465882-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to efaproxiral 0.37 µM for 24.0 h


TSS465883-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to efaproxiral 0.125 µM for 24.0 h


TSS570792-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to efaproxiral 0.25 µM for 24.0 h


TSS570793-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to efaproxiral 0.08 µM for 24.0 h


TSS570790-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to efaproxiral 2.22 µM for 24.0 h


TSS570791-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to efaproxiral 0.74 µM for 24.0 h


TSS570794-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to efaproxiral 0.03 µM for 24.0 h


TSS570795-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to efaproxiral 0.01 µM for 24.0 h


TSS466202-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to efaproxiral 1.11 µM for 24.0 h


TSS466200-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to efaproxiral 10.0 µM for 24.0 h


TSS466201-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to efaproxiral 3.33 µM for 24.0 h


TSS466203-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to efaproxiral 0.37 µM for 24.0 h


TSS466204-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to efaproxiral 0.125 µM for 24.0 h


TSS466205-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to efaproxiral 0.04 µM for 24.0 h


TSS571128-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to efaproxiral 0.08 µM for 24.0 h


TSS571125-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to efaproxiral 2.22 µM for 24.0 h


TSS571126-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to efaproxiral 0.74 µM for 24.0 h


TSS571127-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to efaproxiral 0.25 µM for 24.0 h


TSS571129-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to efaproxiral 0.03 µM for 24.0 h


TSS571130-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to efaproxiral 0.01 µM for 24.0 h


TSS466526-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to efaproxiral 10.0 µM for 24.0 h


TSS466527-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to efaproxiral 3.33 µM for 24.0 h


TSS466528-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to efaproxiral 1.11 µM for 24.0 h


TSS466529-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to efaproxiral 0.37 µM for 24.0 h


TSS466530-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to efaproxiral 0.125 µM for 24.0 h


TSS466531-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to efaproxiral 0.04 µM for 24.0 h


TSS571462-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to efaproxiral 0.25 µM for 24.0 h


TSS571460-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to efaproxiral 2.22 µM for 24.0 h


TSS571461-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to efaproxiral 0.74 µM for 24.0 h


TSS571464-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to efaproxiral 0.03 µM for 24.0 h


TSS571463-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to efaproxiral 0.08 µM for 24.0 h


TSS571465-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to efaproxiral 0.01 µM for 24.0 h


TSS466856-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to efaproxiral 10.0 µM for 24.0 h


TSS466859-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to efaproxiral 0.37 µM for 24.0 h


TSS466857-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to efaproxiral 3.33 µM for 24.0 h


TSS466858-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to efaproxiral 1.11 µM for 24.0 h


TSS466861-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to efaproxiral 0.04 µM for 24.0 h


TSS466860-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to efaproxiral 0.125 µM for 24.0 h


TSS571796-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to efaproxiral 0.74 µM for 24.0 h


TSS571795-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to efaproxiral 2.22 µM for 24.0 h


TSS571797-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to efaproxiral 0.25 µM for 24.0 h


TSS571798-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to efaproxiral 0.08 µM for 24.0 h


TSS571799-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to efaproxiral 0.03 µM for 24.0 h


TSS571800-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to efaproxiral 0.01 µM for 24.0 h


TSS467186-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to efaproxiral 10.0 µM for 24.0 h


TSS467187-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to efaproxiral 3.33 µM for 24.0 h


TSS467188-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to efaproxiral 1.11 µM for 24.0 h


TSS467189-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to efaproxiral 0.37 µM for 24.0 h


TSS467190-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to efaproxiral 0.125 µM for 24.0 h


TSS467191-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to efaproxiral 0.04 µM for 24.0 h


TSS572130-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to efaproxiral 2.22 µM for 24.0 h


TSS572131-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to efaproxiral 0.74 µM for 24.0 h


TSS572132-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to efaproxiral 0.25 µM for 24.0 h


TSS572133-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to efaproxiral 0.08 µM for 24.0 h


TSS572134-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to efaproxiral 0.03 µM for 24.0 h


TSS572135-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to efaproxiral 0.01 µM for 24.0 h


TSS467481-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to efaproxiral 10.0 µM for 24.0 h


TSS467482-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to efaproxiral 3.33 µM for 24.0 h


TSS467483-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to efaproxiral 1.11 µM for 24.0 h


TSS467484-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to efaproxiral 0.37 µM for 24.0 h


TSS467485-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to efaproxiral 0.125 µM for 24.0 h


TSS467486-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to efaproxiral 0.04 µM for 24.0 h


TSS572460-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to efaproxiral 2.22 µM for 24.0 h


TSS572461-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to efaproxiral 0.74 µM for 24.0 h


TSS572462-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to efaproxiral 0.25 µM for 24.0 h


TSS572463-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to efaproxiral 0.08 µM for 24.0 h


TSS572464-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to efaproxiral 0.03 µM for 24.0 h


TSS572465-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to efaproxiral 0.01 µM for 24.0 h


TSS467806-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to efaproxiral 10.0 µM for 24.0 h


TSS467809-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to efaproxiral 0.37 µM for 24.0 h


TSS467807-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to efaproxiral 3.33 µM for 24.0 h


TSS467808-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to efaproxiral 1.11 µM for 24.0 h


TSS467810-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to efaproxiral 0.125 µM for 24.0 h


TSS467811-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to efaproxiral 0.04 µM for 24.0 h


TSS572795-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to efaproxiral 2.22 µM for 24.0 h


TSS572800-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to efaproxiral 0.01 µM for 24.0 h


TSS572796-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to efaproxiral 0.74 µM for 24.0 h


TSS572797-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to efaproxiral 0.25 µM for 24.0 h


TSS572798-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to efaproxiral 0.08 µM for 24.0 h


TSS572799-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to efaproxiral 0.03 µM for 24.0 h


TSS468091-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to efaproxiral 1.11 µM for 24.0 h


TSS468089-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to efaproxiral 10.0 µM for 24.0 h


TSS468090-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to efaproxiral 3.33 µM for 24.0 h


TSS468092-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to efaproxiral 0.37 µM for 24.0 h


TSS468093-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to efaproxiral 0.125 µM for 24.0 h


TSS468094-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to efaproxiral 0.04 µM for 24.0 h


TSS573132-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to efaproxiral 0.08 µM for 24.0 h


TSS573129-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to efaproxiral 2.22 µM for 24.0 h


TSS573130-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to efaproxiral 0.74 µM for 24.0 h


TSS573131-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to efaproxiral 0.25 µM for 24.0 h


TSS573133-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to efaproxiral 0.03 µM for 24.0 h


TSS573134-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to efaproxiral 0.01 µM for 24.0 h


TSS468420-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to efaproxiral 10.0 µM for 24.0 h


TSS468423-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to efaproxiral 0.37 µM for 24.0 h


TSS468421-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to efaproxiral 3.33 µM for 24.0 h


TSS468422-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to efaproxiral 1.11 µM for 24.0 h


TSS468424-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to efaproxiral 0.125 µM for 24.0 h


TSS468425-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to efaproxiral 0.04 µM for 24.0 h


TSS573466-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to efaproxiral 0.25 µM for 24.0 h


TSS573469-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to efaproxiral 0.01 µM for 24.0 h


TSS573464-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to efaproxiral 2.22 µM for 24.0 h


TSS573465-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to efaproxiral 0.74 µM for 24.0 h


TSS573467-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to efaproxiral 0.08 µM for 24.0 h


TSS573468-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to efaproxiral 0.03 µM for 24.0 h



TSP48938 - CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to efaproxiral Public

https://clue.io/data/CMap2020#LINCS2020

Experimental design

No experimental design provided

Results

No results provided